Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)

China · Delayed Price · Currency is CNY

11.86

-0.12 (-1.00%)

Apr 30, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Preparations	601.65M					-	-	-	-
Active Pharmaceutical Ingredient (API)	100.29M					-	-	-	-
Intermediates and Others	3.41M					-	-	-	-
Traditional Chinese Medicine	4.00M					-	-	-	-
Food	2.96M					-	-	-	-
Pharmaceuticals	-					681.23M	545.77M	340.89M	321.22M
Pharmaceuticals Growth	-					24.82%	60.10%	6.12%	1.35%
Total	712.31M					681.23M	545.77M	340.89M	321.22M
Total Growth	-					24.82%	60.10%	6.12%	1.35%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	695.71M					-	-	-	260.86M
China Growth	-					-	-	-	4.04%
Overseas	16.60M					-	-	-	38.91M
Overseas Growth	-					-	-	-	-26.25%
Total	712.31M					-	-	-	299.78M
Total Growth	-					-	-	-	-1.23%

Source: S&P Global Market Intelligence.